Results 1 to 10 of about 241,406 (405)
Differential impact of two risk communications on antipsychotic prescribing to people with dementia in Scotland: segmented regression time series analysis 2001-2011 [PDF]
, 2013The two risk communications were associated with reductions in antipsychotic use, in ways which were compatible with marked differences in their content and dissemination.
A Libby+24 more
core +21 more sources
Biomolecules, 2022
The ventral tegmental area (VTA) in the ventral midbrain is the origin of the dopaminergic neurotransmission pathways. Although GABAA receptors and AKT-GSK3β signaling are involved in the pathophysiology of mental disorders and are modulated by ...
Shiyan Chen+3 more
doaj +1 more source
The ventral tegmental area (VTA) in the ventral midbrain is the origin of the dopaminergic neurotransmission pathways. Although GABAA receptors and AKT-GSK3β signaling are involved in the pathophysiology of mental disorders and are modulated by ...
Shiyan Chen+3 more
doaj +1 more source
Frontiers in Cellular Neuroscience, 2022
Introduction: Neuroinflammation in the central nervous system, particularly the prefrontal cortex (PFC), plays a role in the pathogenesis of schizophrenia, which has been found to be associated with maternal immune activation (MIA).
Yueqing Su+9 more
doaj +1 more source
Introduction: Neuroinflammation in the central nervous system, particularly the prefrontal cortex (PFC), plays a role in the pathogenesis of schizophrenia, which has been found to be associated with maternal immune activation (MIA).
Yueqing Su+9 more
doaj +1 more source
World Psychiatry, 2020
Antipsychotics are effective in preventing relapses of schizophrenia, but it is generally believed that their long‐term use is harmful for patients’ physical well‐being. However, there are no long‐term studies which have verified this view.
H. Taipale+5 more
semanticscholar +1 more source
Antipsychotics are effective in preventing relapses of schizophrenia, but it is generally believed that their long‐term use is harmful for patients’ physical well‐being. However, there are no long‐term studies which have verified this view.
H. Taipale+5 more
semanticscholar +1 more source
Real-World Functioning in Patients With Schizophrenia: Beyond Negative and Cognitive Symptoms
Frontiers in Psychiatry, 2021Introduction: Interest in the idea of recovery for certain patients with schizophrenia has been growing over the last decade. Improving symptomatology and functioning is crucial for achieving this.
María Paz García-Portilla+39 more
doaj +1 more source
Risperidone response in patients with schizophrenia drives DNA methylation changes in immune and neuronal systems [PDF]
, 2023Background: The choice of efficient antipsychotic therapy for schizophrenia relies on a time-consuming trial-and-error approach, whereas the social and economic burdens of the disease call for faster alternatives. Material \& methods: In a search for predictive biomarkers of antipsychotic response, blood methylomes of 28 patients were analyzed before ...
arxiv +1 more source
Dreams, Sleep, and Psychotropic Drugs
Frontiers in Neurology, 2020Over the past 60 years, the impact of psychotropic drugs on dream recall and content has been scarcely explored. A review of the few existing experimental results on the topic leads us to the following conclusions.
Alain Nicolas, Perrine M. Ruby
doaj +1 more source
Mechanistic modeling as an explanatory tool for clinical treatment of chronic catatonia
Frontiers in Pharmacology, 2022Mathematical modeling of neural systems is an effective means to integrate complex information about the brain into a numerical tool that can help explain observations. However, the use of neural models to inform clinical decisions has been limited.
Patrick D. Roberts, James Conour
doaj +1 more source
Antipsychotics and dementia [PDF]
BMC Geriatrics, 2010Background In recent years use of antipsychotics was widely debated for concerns about their safety in elderly patients affected with dementia [1,2].
G. De Sarro+6 more
openaire +3 more sources
Acute olanzapine toxicity in a toddler
Open Journal of Psychiatry and Allied Sciences, 2020Olanzapine is an antipsychotic medication, which is approved for treatment of psychiatric illnesses among various age groups of psychiatric patients. Accidental consumption of olanzapine is uncommon among the paediatric age group.
Hemendra Singh+3 more
doaj +1 more source